Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families

Fig. 1

The effect of Isoniazid on M. tuberculosis Uganda II, Beijing and Delhi/CAS. Panel A1, aerobic conditions. control b, Beijing with no drug; control c, Delhi/CAS with no drug; control u, Uganda II with no drug; ce0.03 μg/ml, Delhi/CAS at 1x MIC; ue0.5 μg/ml, Uganda II at 1x MIC; be0.03 μg/ml, Beijing at 1x MIC; ce0.06 μg/ml, Delhi/CAS at 2x MIC; ue1 μg/ml, Uganda II at 2x MIC; be0.06 μg/ml, Beijing at 2x MIC; ce0.15 μg/ml, Delhi/CAS at 5x MIC; ue2.5 μg/ml, Uganda II at 5x MIC; be0.06 μg/ml, Beijing at 5x MIC. Panel A2, same as in Panel A1 but under oxygen-depleted conditions

Back to article page